首页> 外文会议>International symposium on controlled release of bioactive materials;Consumer and diversified products conference >Incorporation of tolmetin into polyasparthylhydrazide networks. effects on drug release and photochemical alteration
【24h】

Incorporation of tolmetin into polyasparthylhydrazide networks. effects on drug release and photochemical alteration

机译:将托美汀并入聚天冬酰胺酰肼网络中。对药物释放和光化学变化的影响

获取原文

摘要

alpha,beta-polyasparthylhydrazide (PAHy) is a polymer at protein-like structure proposed as plasma expander and drug carrier~1. PAHy can be also used to prepare hydrogel systems and the use of glutaraldehyde (GLU) to crosslink this polymer has been reported. Nevertheless, PAHy-GLU samples undergo a limited swelling in aqueous medium which causes a very slow release of entrapped drug molecules such 5-fluorouracil and cytarabine. In order to overcome this problem, we have chosen as crosslinking agent the ethyleneglycol diglycidylether (EGDGE). Preliminary studies have evidenced an outstanding affinity of PAHy-EGDGE networks towards the aqueous medium and a high stability after chemical and enzymatic treatment. these properties point out the suitability of these hydrogels as systems to release entrapped solutes in a biological medium. Then, our goal is to study the potential use of these networks as drug delivery systems and for this purpose we have prepared PAHy-EGDGE samples containing tolmetin chosen as a model drug, both as water-swellable microparticles and as gel system. The effect of drug loading procedure on drug release rate has been evalauted and hemolysis tests have been performed in order to evalaute the ability of PAHy-EGDGE networks to reduce photosensitization processes induced by Tometin.
机译:α,β-聚天冬酰胺酰肼(PAHy)是一种蛋白质样结构的聚合物,被提议作为血浆扩张剂和药物载体〜1。 PAHy也可用于制备水凝胶体系,并且已报道使用戊二醛(GLU)交联该聚合物。然而,PAHy-GLU样品在水性介质中的溶胀程度有限,这会导致包裹的药物分子(如5-氟尿嘧啶和阿糖胞苷)的释放非常缓慢。为了克服该问题,我们选择了乙二醇二缩水甘油醚(EGDGE)作为交联剂。初步研究表明,PAHy-EGDGE网络对水性介质具有出色的亲和力,并且经过化学和酶处理后具有很高的稳定性。这些性质指出了这些水凝胶作为在生物介质中释放夹带的溶质的系统的适用性。然后,我们的目标是研究这些网络作为药物输送系统的潜在用途,为此,我们制备了含有托美汀(作为模型药物)的PAHy-EGDGE样品,既作为水溶胀性微粒,又作为凝胶体系。评估了载药程序对药物释放速率的影响,并进行了溶血试验,以评估PAHy-EGDGE网络减少Tometin诱导的光敏过程的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号